Intraperitoneal administration of recombinant IL-18 has been demonstrated to exacerbate renal disease [11] and in vivo inhibition of IL-18 by anti-IL-18 cDNA vaccination attenuates lymphoproliferation and nephritis and increases lifespan [14]. The gene discussed is IL18; the disease is kidney disorder.